We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Assessment of a HER2 scoring system for gastric cancer: results from a validation study.
- Authors
Hofmann, M; Stoss, O; Shi, D; Büttner, R; van de Vijver, M; Kim, W; Ochiai, A; Rüschoff, J; Henkel, T
- Abstract
Human epidermal growth factor receptor 2 (HER2) overexpression/amplification is implicated in the development of various solid tumour types. Validated methods and scoring systems for evaluating HER2 status exist in breast cancer, but not in gastric cancer. The aim was to establish a HER2 scoring system for gastric cancer to identify suitable patients for enrollment in a trial of trastuzumab (Herceptin) in advanced metastatic gastric cancer.
- Publication
Histopathology, 2008, Vol 52, Issue 7, p797
- ISSN
1365-2559
- Publication type
Journal Article
- DOI
10.1111/j.1365-2559.2008.03028.x